Works matching DE "DRUG marketing laws"

Results: 36

Regulatory Property: The New IP.

Published in:

Columbia Journal of Law & the Arts, 2016, v. 40, n. 1, p. 53

By:

Feldmanv, Robin

Publication type:

Article

Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 11, p. 947, doi. 10.1007/s00228-006-0193-0

By:

Ceci, A.;
Felisi, M.;
Baiardi, P.;
Bonifazi, F.;
Catapano, M.;
Giaquinto, C.;
Nicolosi, A.;
Sturkenboom, M.;
Neubert, A.;
Wong, I.

Publication type:

Article

The Highs of Tomorrow: Why New Laws and Policies are Needed to Meet the Unique Challenges of Synthetic Drugs.

Published in:

Journal of Law & Health, 2014, v. 27, n. 2, p. 163

By:

Cohen, Joseph A.

Publication type:

Article

PROGRESS IN THE CHALLENGE TO REGULATE ONLINE PHARMACIES.

Published in:

Journal of Law & Health, 2010, v. 23, n. 2, p. 113

By:

Karberg, Jeff

Publication type:

Article

Medicare Part D Prescription Drug Advertising Governed by Federal, Not State, Law.

Published in:

Journal of the Academy of Marketing Science, 2009, v. 37, n. 3, p. 377

By:

Halsey, Brian J.

Publication type:

Article

MJA InSight poll.

Published in:: Medical Journal of Australia, 2013, v. 198, n. 8, p. 395
Publication type:: Article

SALUD Y ALIMENTACIÓN.

Published in:: Actualidad Jurídica (1578-956X), 2014, n. 37, p. 296
Publication type:: Article

SALUD Y ALIMENTACIÓN.

Published in:: Actualidad Jurídica (1578-956X), 2014, n. 36, p. 244
Publication type:: Article

SALUD Y ALIMENTACIÓN.

Published in:: Actualidad Jurídica (1578-956X), 2013, n. 34, p. 242
Publication type:: Article

FDA Issues Updated Draft Guidance on Reporting Drug Samples.

Published in:

Journal of Health Care Compliance, 2014, v. 16, n. 5, p. 65

By:

SANZO, KATHLEEN;
OSOWSKI, REBECCA

Publication type:

Article

Safety: a long-term view.

Published in:: 2012
Publication type:: Opinion

THE DATA DIVIDE: MANAGING THE MISALIGNMENT IN CANADA'S EVIDENTIARY REQUIREMENTS FOR DRUG REGULATION AND FUNDING.

Published in:

University of British Columbia Law Review, 2012, v. 45, n. 2, p. 283

By:

FLOOD, COLLEEN M.;
DYKE, PATRICK

Publication type:

Article

Safety Requirements Slow Drug Approvals.

Published in:

Applied Clinical Trials, 2009, v. 18, n. 11, p. 24

By:

Wechsler, Jill

Publication type:

Article

PHARMACEUTICAL ADVERTISING DISCLOSURES: IS LESS REALLY MORE?

Published in:

Quinnipiac Health Law Journal, 2019, v. 22, n. 3, p. 449

By:

Giancarlo, Taylor

Publication type:

Article

Dangerous Times: The FDA's Role in Information Production, Past and Future.

Published in:

Minnesota Law Review, 2018, v. 102, n. 6, p. 2357

By:

Kapczynski, Amy

Publication type:

Article

SHRINKING DRUG COSTS WITHOUT SILENCING PHARMACEUTICAL DETAILERS: MARYLAND'S OPTIONS AFTER SORRELL V. IMS HEALTH.

Published in:

Journal of Health Care Law & Policy, 2013, v. 16, n. 1, p. 215

By:

MILLER, KRISTINA L.

Publication type:

Article

Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law.

Published in:

Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 620, doi. 10.1111/jlme.12071

By:

Feldman, Yuval;
Gauthier, Rebecca;
Sehuler, Troy

Publication type:

Article

LOOKING INWARD: REGIONAL PARALLEL TRADE AS A MEANS OF BRINGING A AFFORDABLE DRUGS TO AFRICA.

Published in:

2011

By:

Buckley, Marianne

Publication type:

Opinion

President's Message.

Published in:

South African Pharmaceutical Journal, 2013, v. 80, n. 7, p. 5

By:

Kruger, Johann

Publication type:

Article

DETAILING COMMERCIAL SPEECH: WHAT PHARMACEUTICAL MARKETING REVEALS ABOUT BANS ON COMMERCIAL SPEECH.

Published in:

William & Mary Bill of Rights Journal, 2013, v. 21, n. 4, p. 1291

By:

Wolf, Andrew J.

Publication type:

Article

Off-Label Drug Marketing, the First Amendment, and Federalism.

Published in:

Washington University Journal of Law & Policy, 2016, v. 50, p. 89

By:

Orentlicher, David

Publication type:

Article

THE LAW, ECONOMICS, AND MEDICINE OF OFF-LABEL PRESCRIBING.

Published in:

Washington Law Review, 2016, v. 91, n. 1, p. 119

By:

Comanor, William S.;
Needleman, Jack

Publication type:

Article

Global Implications of the EU's Pharmacovigilance System Master File Requirements: Newly Developed Decision Trees to Distinguish Different Study Types.

Published in:

Pharmaceutical Medicine, 2015, v. 29, n. 6, p. 323, doi. 10.1007/s40290-015-0116-4

By:

Kaehler, Stefan;
Minton, Neil;
Walsh, Nancy;
Gillen, David;
Bwire, Robert;
Freeman, John

Publication type:

Article

Patent Term Extensions and the Last Man Standing.

Published in:

Yale Law & Policy Review, 2023, v. 42, n. 1, p. 1

By:

Feldman, Robin

Publication type:

Article

PROSPECTS FOR REGULATION OF OFF-LABEL DRUG PROMOTION IN AN ERA OF EXPANDING COMMERCIAL SPEECH PROTECTION.

Published in:

North Carolina Law Review, 2014, v. 92, n. 5, p. 1539

By:

KESSELHEIM, AARON S.;
MELLO, MICHELLE M.

Publication type:

Article

FDA plans to continue cracking down on unapproved drugs.

Published in:

American Journal of Health-System Pharmacy, 2008, v. 65, n. 17, p. 1594, doi. 10.2146/news080072

By:

Lavine, Greg

Publication type:

Article

Prohibition against off-label drug promotion challenged.

Published in:

Canadian Medical Association Journal (CMAJ), 2012, v. 184, n. 5, p. 518, doi. 10.1503/cmaj.109-4128

By:

Woodward, Cal

Publication type:

Article

Systemic violence in drug markets.

Published in:

Crime, Law & Social Change, 2009, v. 52, n. 3, p. 275, doi. 10.1007/s10611-009-9197-x

By:

Reuter, Peter

Publication type:

Article

THE WORLD IN MEDICINE.

Published in:

JAMA: Journal of the American Medical Association, 2008, v. 300, n. 23, p. 2717

By:

Stephenson, Joan

Publication type:

Article

Consumer Drug Ads.

Published in:

JAMA: Journal of the American Medical Association, 2008, v. 299, n. 22, p. 2620, doi. 10.1001/jama.299.22.2620-d

By:

Mitka, Mike

Publication type:

Article

Direct-to-Consumer Drug Advertisements and the Informed Patient: A Legal, Ethical, and Content Analysis.

Published in:

American Business Law Journal, 2013, v. 50, n. 4, p. 729, doi. 10.1111/ablj.12019

By:

Perry, Joshua E.;
Cox, Anthony D.;
Cox, Dena

Publication type:

Article

European Medicines Agency decides to suspend Avandia.

Published in:: Podiatry Review, 2010, v. 67, n. 6, p. 2
Publication type:: Article

Drug promotion in Australia: Policy contestation and the tightening of regulation.

Published in:

Australian Review of Public Affairs: Journal, 2013, v. 11, n. 2, p. 19

By:

Doran, Evan;
Löfgren, Hans

Publication type:

Article

Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study.

Published in:

Journal of Public Health, 2005, v. 27, n. 1, p. 19, doi. 10.1093/pubmed/fdh216

By:

Morgan, Oliver;
Griffiths, Clare

Publication type:

Article

SEX, DRUGS, AND ADVISORY COMMITTEES: AN ANALYSIS OF PHARMACEUTICAL INDUSTRY MANIPULATION OF FDA VULNERABILITY TO SOCIOPOLITICAL INFLUENCES ON MATTERS OF WOMEN’S HEALTH.

Published in:

Columbia Human Rights Law Review, 2017, v. 48, n. 2, p. 149

By:

Sanders, Mara

Publication type:

Article

Gun Carrying Among Drug Market Participants: Evidence from Incarcerated Drug Offenders.

Published in:

Journal of Quantitative Criminology, 2015, v. 31, n. 3, p. 435, doi. 10.1007/s10940-014-9233-6

By:

Sevigny, Eric;
Allen, Andrea

Publication type:

Article